$36.8 Million is the total value of Telemetry Investments, L.L.C.'s 65 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
DIS | DISNEY WALT CO | $769,000 | +15.3% | 6,900 | 0.0% | 2.09% | -10.4% | |
DIS | DISNEY WALT COcall | $769,000 | +15.3% | 6,900 | 0.0% | 2.09% | -10.4% | |
DIS | DISNEY WALT COput | $769,000 | +15.3% | 6,900 | 0.0% | 2.09% | -10.4% | |
GLD | SPDR GOLD TR | $753,000 | +13.1% | 4,500 | 0.0% | 2.04% | -12.1% | |
XOM | EXXON MOBIL CORPput | $724,000 | +17.7% | 16,200 | 0.0% | 1.97% | -8.5% | |
XOM | EXXON MOBIL CORPcall | $724,000 | +17.7% | 16,200 | 0.0% | 1.97% | -8.5% | |
RIGL | RIGEL PHARMACEUTICALS INC | $413,000 | +17.3% | 225,500 | 0.0% | 1.12% | -8.9% | |
GSAT | GLOBALSTAR INC | $397,000 | +10.9% | 1,215,812 | 0.0% | 1.08% | -13.8% | |
BAC | BK OF AMERICA CORPcall | $356,000 | +11.9% | 15,000 | 0.0% | 0.97% | -13.0% | |
BAC | BK OF AMERICA CORPput | $356,000 | +11.9% | 15,000 | 0.0% | 0.97% | -13.0% | |
ELGXQ | ENDOLOGIX INC | $63,000 | +16.7% | 78,460 | 0.0% | 0.17% | -9.5% | |
FBIO | FORTRESS BIOTECH INC | $55,000 | +41.0% | 20,376 | 0.0% | 0.15% | +9.6% | |
ROSEQ | ROSEHILL RES INCcl a | $46,000 | +76.9% | 63,137 | 0.0% | 0.12% | +37.4% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
RIGEL PHARMACEUTICALS INC | 33 | Q4 2022 | 1.7% |
AFFIMED N V | 31 | Q4 2022 | 3.9% |
GLOBALSTAR INC | 30 | Q4 2022 | 2.5% |
VIEWRAY INC | 23 | Q4 2022 | 2.1% |
SPDR GOLD TRUST | 22 | Q4 2022 | 2.3% |
ADMA BIOLOGICS INC | 21 | Q4 2022 | 2.9% |
STEMLINE THERAPEUTICS INC | 21 | Q1 2020 | 1.2% |
SPDR S&P 500 ETF TR | 20 | Q4 2022 | 53.9% |
KADMON HLDGS INC | 19 | Q2 2021 | 7.0% |
EIGER BIOPHARMACEUTICALS INC | 19 | Q4 2022 | 6.7% |
View Telemetry Investments, L.L.C.'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Xtant Medical Holdings, Inc. | February 13, 2020 | 752,915 | 5.7% |
Orexigen Therapeutics, Inc. | February 14, 2019 | 1,295,844 | 6.4% |
Xtant Medical Holdings, Inc. | February 14, 2018 | 1,416,339 | 7.2% |
View Telemetry Investments, L.L.C.'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2023-02-14 |
13F-HR | 2022-11-17 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
13F-HR | 2021-11-15 |
13F-HR | 2021-08-16 |
13F-HR | 2021-05-17 |
13F-HR | 2021-02-16 |
13F-HR | 2020-11-16 |
View Telemetry Investments, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.